Sandy Spring Bank’s Biogen BIIB Stock Holding History

Sandy Spring Bank’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$15.7K	Hold	115	–	–	﹤0.01%	774
2024 Q4	$17.6K	Sell	115 -10	-8%	-$1.69K	﹤0.01%	770
2024 Q3	$24.2K	Hold	125	–	–	﹤0.01%	722
2024 Q2	$29K	Hold	125	–	–	﹤0.01%	687
2024 Q1	$27K	Buy	125 +10	+9%	+$2.34K	﹤0.01%	698
2023 Q4	$29.8K	Hold	115	–	–	﹤0.01%	653
2023 Q3	$29.6K	Hold	115	–	–	﹤0.01%	640
2023 Q2	$32.8K	Hold	115	–	–	﹤0.01%	627
2023 Q1	$32K	Hold	115	–	–	﹤0.01%	614
2022 Q4	$31.8K	Hold	115	–	–	﹤0.01%	606
2022 Q3	$31K	Hold	115	–	–	﹤0.01%	587
2022 Q2	$23K	Hold	115	–	–	﹤0.01%	666
2022 Q1	$24K	Hold	115	–	–	﹤0.01%	668
2021 Q4	$28K	Hold	115	–	–	﹤0.01%	691
2021 Q3	$33K	Hold	115	–	–	﹤0.01%	651
2021 Q2	$40K	Hold	115	–	–	﹤0.01%	623
2021 Q1	$32K	Hold	115	–	–	﹤0.01%	592
2020 Q4	$28K	Sell	115 -17	-13%	-$4.39K	﹤0.01%	580
2020 Q3	$38K	Buy	132 +8	+6%	+$2.23K	﹤0.01%	503
2020 Q2	$33K	Hold	124	–	–	﹤0.01%	518
2020 Q1	$39K	Buy	124 +9	+8%	+$2.73K	﹤0.01%	476
2019 Q4	$34K	Sell	115 -50	-30%	-$13.9K	﹤0.01%	523
2019 Q3	$39K	Buy	165 +50	+43%	+$11.6K	﹤0.01%	502
2019 Q2	$27K	Hold	115	–	–	﹤0.01%	554
2019 Q1	$27K	Sell	115 -25	-18%	-$7.87K	﹤0.01%	528
2018 Q4	$42K	Hold	140	–	–	﹤0.01%	467
2018 Q3	$49K	Hold	140	–	–	﹤0.01%	467
2018 Q2	$41K	Sell	140 -59	-30%	-$16.6K	﹤0.01%	488
2018 Q1	$54K	Sell	199 -9	-4%	-$2.79K	﹤0.01%	465
2017 Q4	$67K	Buy	208 +44	+27%	+$14.1K	0.01%	405
2017 Q3	$52K	Sell	164 -13	-7%	-$3.85K	0.01%	438
2017 Q2	$49K	Buy	177 +24	+16%	+$6.35K	﹤0.01%	457
2017 Q1	$42K	Sell	153 -44	-22%	-$12.4K	﹤0.01%	475
2016 Q4	$56K	Buy	197 +47	+31%	+$13.9K	0.01%	427
2016 Q3	$47K	Hold	150	–	–	0.01%	441
2016 Q2	$36K	Hold	150	–	–	﹤0.01%	490
2016 Q1	$39K	Hold	150	–	–	﹤0.01%	477
2015 Q4	$46K	Sell	150 -40	-21%	-$11.5K	0.01%	432
2015 Q3	$55K	Sell	190 -95	-33%	-$31.4K	0.01%	430
2015 Q2	$115K	Buy	285 +10	+4%	+$4.01K	0.01%	350
2015 Q1	$116K	Sell	275 -28	-9%	-$11K	0.01%	340
2014 Q4	$102K	Buy	303 +29	+11%	+$9.38K	0.01%	325
2014 Q3	$90K	Hold	274	–	–	0.01%	340
2014 Q2	$86K	Buy	274 +128	+88%	+$38.5K	0.01%	351
2014 Q1	$45K	Buy	146 +6	+4%	+$1.91K	0.01%	387
2013 Q4	$39K	Hold	140	–	–	0.01%	395
2013 Q3	$34K	Sell	140 -40	-22%	-$8.95K	0.01%	393
2013 Q2	$39K	Buy	+180	New	+$38.5K	0.01%	374

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sandy Spring Bank's BIIB Position: Q1 2025 in Review

Sandy Spring Bank held its Biogen (BIIB) position steady in Q1 2025 at 115 shares worth $15.7K. The position accounts for ﹤0.01% of the portfolio, ranked #774.

Sandy Spring Bank first reported a position in BIIB in Q2 2013 and has held it in 48 quarters since. The position peaked at $116K in Q1 2015. 882 funds tracked by Wall St. Rank hold BIIB as of Q1 2025.

Sandy Spring Bank held 115 shares of Biogen worth $15.7K as of Q1 2025.
Sandy Spring Bank left its Biogen share count unchanged in Q1 2025.
Biogen made up ﹤0.01% of Sandy Spring Bank's portfolio in Q1 2025, its #774 holding.
Sandy Spring Bank first reported a position in Biogen in Q2 2013 and has held it in 48 quarters since.
Sandy Spring Bank's Biogen position peaked at $116K in Q1 2015.
882 funds tracked by Wall St. Rank held Biogen as of Q1 2025.

Based on Sandy Spring Bank's 13F filing for Q1 2025, filed 12 May 2025.